Skip to main content

Advertisement

Table 5 Relapse rate classification. Comparison of the results of clinical, endoscopic and histopathological examinations conducted before treatment and after 6 months

From: The evaluation of three treatment protocols using oral prednisone and oral meloxicam for therapy of canine idiopathic lymphoplasmacytic rhinitis: a pilot study

  Before treatment 6 months after treatment Relapse rate%
Group Dog Clinical signs Endoscopic changes Histopathological changes Clinical signs Endoscopic changes Histopathological changes
1 A +++ +++ ++ + + ++ (12,5/25) 50
B ++ ++ + + + +
C + + + + +
D + + + +/−
E ++ ++ ++ + + +
Total 25 12,5
2 A +++ +++ +++ (0/29) 0
B ++ + +
C ++ ++ ++
D + + ++
E ++ + ++
Total 29 0
3 A +++ +++ +++ ++ ++ +++ (22/29) 75
B ++ ++ ++ + + ++
C ++ ++ ++ + + ++
D + + ++ + + +
E + ++ + + + ++
Total 29 22
  1. - no changes (score of 0 points)
  2. +/− unremarkable
  3. + mild signs/changes (score of 1–3 points)
  4. ++ moderate signs/changes (score of 4–6 points)
  5. +++ severe signs/changes (score of 7–9 points)
  6. Group 1 - prednisone (Encorton)
  7. Group 2- meloxicam (Gromeloksin), followed by prednisone (Encorton)
  8. Group 3- meloxicam (Gromeloksin)
  9. Group 4- placebo (empty gelatin capsules)